期刊文献+

咪唑并[1,2-a]嘧啶类化合物的合成和抗炎活性 被引量:5

Synthesis and anti-inflammatory activities of imidazo [1,2-a] pyrimidinederivatives
下载PDF
导出
摘要 目的:研究具有咪唑并[1,2-a]嘧啶结构化合物的合成和抗炎活性。方法:在咪唑并[1,2-a]嘧啶的结构基础上,合成2-位和3-位上有两个芳香性取代基的咪唑并[1,2-a]嘧啶类化合物(5a~5o),并对所合成的化合物进行二甲苯诱导的小鼠耳肿胀模型抗炎活性实验。结果:合成的15个未见报道的目标化合物结构经元素分析,红外光谱、核磁共振氢谱、质谱确证;初步生物活性测试表明,多数化合物具有不同程度的抗炎活性,其中化合物5d,5f和5l的活性较好。结论:与布洛芬相比,咪唑并[1,2-a]嘧啶类化合物能保持中等的抗炎活性,2-位和3-位被两个相邻的芳基取代可以改善COX-2的抑制作用。 Aim: To synthesize and characterize a series of imidazo[ 1,2-a] pyrimidine derivatives, and to evaluate their anti-inflammatory activities. Methods: Based on the analysis of the structure of imidazo[ 1,2-a] pyrimidine, a series of compounds (5a-5o) substituted adjacently with two aryls at positions 2 and 3 were designed and synthesized. Their anti-inflammatory activities were evaluated by means of xylene-induced ear swelling in mice. Results: Their structures were confirmed by ^1H NMR, IR, MS and elemental analysis. It was found that most of the synthesized compounds possessed the anti-inflammatory activity, of which compound 5d, 5f and 5I showed the most potent activity. Conclusion: Imidazo[ 1,2-a] pyrimidine compounds keep moderate anti-inflammatory activities as compared with that of ibuprofen.
出处 《中国药科大学学报》 CAS CSCD 北大核心 2009年第1期16-20,共5页 Journal of China Pharmaceutical University
基金 国家自然科学基金资助项目(No.30772647)~~
关键词 咪唑并[1 2-a]嘧啶 合成 环氧合酶-2 抗炎活性 imidazo[ 1,2-a] pyrimidine synthesis cyclooxygenase-2 anti-inflammation
  • 相关文献

参考文献8

  • 1Dannhandt G, Kiefer W. Cyclooxygenase inhibitors-current status and future prospects [ J ]. Eur J Med Chem, 2001, 36(2) :109 -126. 被引量:1
  • 2Pratico D, Dogne JM. Selective cyclooxygenase-2 inhibitors development in cardiovascular medicine [ J ]. Circulation,2005,112 (7) :1 073 -1 079. 被引量:1
  • 3Kumumbail PG, Stevens AM, Gierse JK, et al. Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agent[J]. Nature,1996,384(6 610) :644 -648. 被引量:1
  • 4宣云遐,王明伟.非甾体抗炎药物的研究应用现状[J].生命科学,2005,17(1):10-14. 被引量:7
  • 5Takashi M, Yoshiyuki O, Rodney W. Benzimidazole compounds: EP,0846689 [ P]. 1998-06-10 [ 2008-10-23 ]. 被引量:1
  • 6Laneri S,Sacchi A,Rossi F,et al. Research on heterocyclic compounds-Part ⅩⅩⅩⅨ. 2-Methylimidazo [ 1,2-a ] pyrimidine-3-carboxylic derivatives : synthesis and antiinflammatory activity [ J ]. Eur J Med Chem, 1998,33 (3) : 163 - 170. 被引量:1
  • 7Sacchi A, Ablignente E, Rossi F, et al. Research on heterocyclic compounds. Part ⅩⅩⅩⅥ. Imidazo[ 1,2-a] pyrimidine 2-acetic derivatives:synthesis and antiinflammatory activity [ J ]. Eur J Med Chem, 1997,32 (7-8) :677 - 682. 被引量:1
  • 8Sonia L, Antonia S, Enrico A. Research on heterocyclic compounds. XLⅡ. The vilsmeier reaction in the synthesis of imidazo [ 1,2-a] pyrimidine derivatives [ J ]. J Heterocycl Chem, 2000,37 (5) :1 265 -1 267. 被引量:1

二级参考文献29

  • 1国家食品药品监督管理局药品评估中心.[DB/OL].http://www.cdr.gov.cn/doc/content_jsp.,2005_01_16. 被引量:1
  • 2俊德.FDA警告:慎用环氧合酶-2抑制剂和萘普生[N].中国医药报,2005-01-11(8). 被引量:1
  • 3Needleman P, Isakson P C. The discovery and function of COX-2. J Rheumatol, 1997, 24 (Supp149):6-8. 被引量:1
  • 4Amit S K, Alan B M, Brendan C C, et al. Ester and amide derivatives of the nonsteroidal anti-inflammatory drug,indomethacin, as selective cyclooxygenase-2 inhibitors. J Med Chem, 2000, 43(15): 2860~2870. 被引量:1
  • 5Hawkey C J. COX-2 inhibitor. Lancet, 1999, 353(9149):307-314. 被引量:1
  • 6Willoughby D A,Moore A R,Colville P R.Cox-1,Cox-2 andCox-3and the future treatment of chronic inflammatory disease.Lancet,2000,355(9204):646-648. 被引量:1
  • 7Vane J R, Booting R M. Mechanism of action of nonsteroidal anti-inflammatory drugs. Am J Med, 1998, 104(3A):2S-8S. 被引量:1
  • 8Christopher J. Nonsteroidal anti-inflammatory drugs and the gastrointestinal tract: consensus and controversy. Am J Med, 2001, 110(IA): 1S-3S. 被引量:1
  • 9Raymond V G. Merck announce voluntary worldwide withdrawal of VIOXX [DB/OL]. http://www.vioxx.com/rofecoxib/vioxx/consumer/index.jsp, 2004-09-30. 被引量:1
  • 10Pfizer statement on new information regarding cardiovascular safety of celebrex [DB/OL]. http://www.celebrex.com/cardiovascular_safety_ of_celebrex_tp.asp, 2004-12-17. 被引量:1

共引文献6

同被引文献40

  • 1黄润秋,李慧英,马军安,邱德文.4-肟醚基喹唑啉类化合物的合成及其抗植物病毒TMV活性[J].高等学校化学学报,1996,17(4):571-574. 被引量:23
  • 2蔡继平,蒋华江,林显明.3(5)-氨基吡唑的合成工艺改进[J].化工时刊,2006,20(5):15-16. 被引量:4
  • 3罗宣干,卓仁禧,李满庆.5-氟脲嘧啶的D-氨基葡萄糖衍生物的合成及其抗肿瘤活性的研究[J].高等学校化学学报,1996,17(9):1416-1420. 被引量:46
  • 4Loiseau P R,Payard M,Grassy G,et al.Nouveaux composés de type azaindolizine:étude in vitro de la prévention du bronchospasme[J].Eur J Med Chem,1987,22(5):457-462. 被引量:1
  • 5Rival Y,Grassy G,Taudou A,et al.Antifungal activity in vitro of some imidazo[1,2-a]pyrimidine derivatives[J].Eur J Med Chem,1991,26(1):13-18. 被引量:1
  • 6Clements J S,Danswan G,Gardner C R,et al.(Imidazo[1,2-a]pyrimidin-2-yl) phenylmethanones and related compounds as potential nonsedative anxiolytics[J].J Med Chem,1988,31(16):1220-1226. 被引量:1
  • 7Adib M,Sheibani E,Bijanzadeh H R,et al.A new,one-pot,multi-component synthesis of imines of 3-amino-2-arylimidazo[1,2-a]pyridines,3-amino-2-arylimidazo[1,2-a]pyrazines,and 3-amino-2-arylimidazo[1,2-a]pyrimidines[J].Tetrahedron,2008,64 (47):10681-10686. 被引量:1
  • 8Goodacre S C,Haller D J,Carling R W,et al.Imidazo[1,2-a]pyrazin-8-ones,imidazo[1,2-d][1,2,4]triazin-8-ones and imidazo[2,l-f][1,2,4]triazin-8-ones as a2/a3 subtypeselective GABAA agonists for the treatment of anxiety[J].Bioorg Med Chem Lett,2006,16(6):1582-1585. 被引量:1
  • 9Bardini G Dicembrini I, Cresci B, et al. Inflammation markers and metabolic characteristics of subjects with 1-H plasma glucose levels [J]. Diabetes Care, 2010, 33(2): 411-413. 被引量:1
  • 10Coussens L M, Werb Z. Inflammation and cancer [J]. Nature, 2002, 420(6917): 860-867. 被引量:1

引证文献5

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部